Related Experiment Video
Updated: May 6, 2026
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.1K
Colorectal Cancer Control Program grantees' use of evidence-based interventions
Peggy A Hannon1, Annette E Maxwell, Cam Escoffery
1Health Promotion Research Center, Department of Health Services, School of Public Health, University of Washington, Seattle, Washington.
American Journal of Preventive Medicine
|October 22, 2013
Summary
Most colorectal cancer (CRC) control programs use evidence-based interventions (EBIs), but the most impactful ones for CRC screening are less common. Further research is needed to optimize EBI implementation for better population health outcomes.
Area of Science:
- Public Health
- Cancer Prevention
- Health Services Research
Background:
- Colorectal cancer (CRC) screening is crucial for adults aged 50-75, but screening rates remain low, particularly among uninsured populations.
- The Centers for Disease Control and Prevention (CDC) launched the Colorectal Cancer Control Program (CRCCP) in 2009 to improve CRC screening rates.
- CRCCP funds 29 grantees to screen uninsured individuals and promote CRC screening at a population level.
Purpose of the Study:
- To evaluate the utilization of evidence-based interventions (EBIs) by CRCCP grantees.
- To assess which EBIs are being implemented to promote colorectal cancer screening.
Main Methods:
- A web-based survey was administered in 2011 to CRCCP grantees.
- The survey collected data on the use of CRC screening EBIs and identified implementation partners.
- Data analysis was conducted in 2012.
Main Results:
- Twenty-eight (97%) grantees responded to the survey.
- Small media interventions were most commonly used (96%), followed by client reminders (75%).
- Provider-oriented EBIs, such as provider reminders (32%) and provider assessment and feedback (50%), were less frequently implemented and perceived as more challenging.
Conclusions:
- While most grantees implement EBIs for CRC screening promotion, the adoption of high-impact interventions is limited in the early years of the CRCCP.
- Provider-oriented EBIs, potentially crucial for increasing screening, require further attention and support for successful implementation.
Related Concept Videos
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
682
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
682